Full Text (PDF)
Original Article

Can Granulocyte-Monocyte Colony Stimulating Factor Prevent Fatality in Methotrexate Toxicity? A Case Series with Review of Literature

Dhvani Tushar Chaudhary , 1 Dhvani Tushar Chaudhary , 2Ashka D Shah , 3Sejal H Thakkar , 4Raksha M Patel

Author Information

Licence:




RFP Journal of Dermatology 6(1):p 27-30, January-June 2021. | DOI:

How Cite This Article:

DhvaniTushar Chaudhary, Ashka D Shah, Sejal H Thakkar, Raksha M Patel,Can Granulocyte-Monocyte Colony Stimulating Factor Prevent Fatality in Methotrexate Toxicity? A Case Series with Review of Literature. RFP Journal ofDermatology 2021; 6(1):27–30.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Introduction: Methotrexate (MTX) is a widely used immunosuppressive drug. Though being safe, it has some non-fatal and fatal side effects. Granulocyte-monocyte colony stimulating factor (GM-CSF) a hemopoietic growth factor, is an upcoming preventive and therapeutic modality to curb harmful effects of bone marrow suppressive drugs.Case series: Herein, we narrate three cases of acute MTX toxicity. Two of these presented with cutaneous ulcerative lesions while one presented with only constitutional symptoms. Two patients had derailed liver function tests while one had altered renal function tests. All showed pancytopenia.GM-CSF was given in two cases which responded well, whereas one succumbed to death before administration.Conclusion: Pre-treatment and periodic monitoring; strict avoidance of self-administration are of utmost importance when patient is on MTX. GM-CSF needs exploration in MTX toxicity treatment, and could be a pivotal drug in prevention of fatality in presence of pancytopenia.

Keywords: Methotrexate; Adverse Drug Reaction; Ulceration; Pancytopenia; Self-Medication.


References

No records found.


About this article


Cite this article

DhvaniTushar Chaudhary, Ashka D Shah, Sejal H Thakkar, Raksha M Patel,Can Granulocyte-Monocyte Colony Stimulating Factor Prevent Fatality in Methotrexate Toxicity? A Case Series with Review of Literature. RFP Journal ofDermatology 2021; 6(1):27–30.


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Monday 26 January 2026, 20:22:52 (IST)


35

Accesses

0
4
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share